Selective adenosine A2A receptor inhibitor SCH58261 reduces oligodendrocyte loss upon brain injury in young rats
Cellular elements of maturing brain are vulnerable to insults, which lead to neurodevelopmental defects. There are no established treatments at present. Here we examined the efficacy of selective adenosine A2A receptor inhibitor SCH58261 to combat brain injury, particularly oligodendrocyte (OL) line...
Main Authors: | Mohamed A. Al-Griw, Rabia O. Alghazeer, Nuri Awayn, Ghalia Shamlan, Areej A. Eskandrani, Afnan M. Alnajeebi, Nouf A. Babteen, Wafa S. Alansari |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Saudi Journal of Biological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319562X20304861 |
Similar Items
-
Assessment of Pharmacokinetics and Metabolism Profiles of SCH 58261 in Rats Using Liquid Chromatography–Mass Spectrometric Method
by: Yuri Park, et al.
Published: (2020-05-01) -
Adenosine A<sub>2A</sub> receptor binding profile of two antagonists, ST1535 and KW6002: consideration on the presence of atypical adenosine A<sub>2A</sub> binding sites
by: Teresa Riccioni, et al.
Published: (2010-08-01) -
Stereoselective Total Synthesis of Macrolide Sch-725674 and C-7-epi-Sch-725674
by: Karunakar Baikadi, et al.
Published: (2019-01-01) -
New Poisson–Sch type inequalities and their applications in quantum calculus
by: Tao Liu, et al.
Published: (2018-07-01) -
A NEW BORNEAN SPECIES OF CINNAMOMUM SCH.
by: a. j. g. h. kostermans
Published: (2014-01-01)